1572300671 BRAND NEW: Definitely Gift Quality! Fast Shipping; usually with Tracking. 100% Satisfaction Guaranteed. More Details: *** CONDITION: This book is absolutely brand new ...and can be given as a gift. . . . SHIPPING: We ship all orders either on the day you placed it or the next business day. And at our extra expense, we typically provide tracking (except we do not usually include tracking for inexpensive books). Please note: if you live in Hawaii or Alaska, Puerto Rico or Guam, please order priority if you need your order quickly because NON-expedited delivery to those far-away places can be very slow (that is the same for every seller; it is a postal issue). Within the lower 48 we are fast! . . . OUR SERVICE: As the thoroughness of this description suggests, we take customer service and your complete satisfaction seriously. We stand by our name and offer an iron-clad 100% satisfaction guarantee. We ship right away, respond quickly to inquiries, and are dedicated to providing elite customer service!Read moreShow Less

New York 1996 Hardcover First Printing. 504 pages. Hardcover with dustjacket. Like New. PSYCHIATRY. Filling a gap in the literature, this volume brings together experts in ...pharmacologic and psychosocial treatment to address the challenges presented by complex psychiatric disorders, with special attention paid to strategies for the treatment-refractory patient. Includes an Index. "...a state-of-the-science text of the biopsychosocial model in action. It should be a 'must' text on the shelf of every mental health researcher and practitioner, and especially in the hands of every resident in psychiatry and graduate student in clinical psychology."-Al D. Fedoravicius, Ph. D. (Key Words: Clinical Psychology, Mark H. Pollack, Mental Health, Michael W. Otto, Psychiatry, Jerrold F. Rosenbaum, Eating Disorders, Anxiety, Mood Disorders).Read moreShow Less

More About
This Textbook

Overview

Integrating pharmacologic and cognitive-behavioral perspectives in the major psychiatric disorders, this book features chapters by expert clinician-researchers who provide readers with up-to-date, practical strategies for the treatment of patients with complex psychiatric disorders, with a particular focus on the treatment-refractory patient. Specifically covering a broad range of the disorders confronted in clinical practice, the book also addresses the management of psychotropic side effects that complicate treatment.

Editorial Reviews

Doody's Review Service

Reviewer: Jeffrey S. Ross, MD (Rush University Medical Center)Description: This is the first edition of a general psychiatric text reviewing the strategies for the treatment of major mental disorders that have failed first line therapies.Purpose: The purpose is to provide the mental health clinician with a comprehensive literature review of treatment options for the treatment-resistant patient. Unlike other books that focus on a specific disorder and its treatment, this book provides a unique overview of strategies for second-line treatment of the many common psychiatric disorders seen in clinical practice, and it addresses both medication and cognitive therapy options.Audience: Although not specifically stated, the intended audience includes all mental health practitioners, especially psychiatrists, who are increasingly expected to manage with proficiency the first-line treatment failure. The editors have compiled an impressive array of clinical psychopharmacology researchers, mostly Harvard-based, to author the individual chapters, and they do a superb job.Features: The book consists of mostly text, but also includes occasional clinically useful tables, graphs, and treatment algorithms. The references appear mostly current, at least through early 1995. The table of contents and index are well organized and complete, and the appearance of the book is simple but effective.Assessment: This is a very well-organized, well-written, and thoroughly researched general psychiatric textbook covering sophisticated management approaches for the first-line treatment failure. Although much of the information is highly duplicated in the many disorder-specific textbooks available, this book appears unique in compiling this clinically invaluable information into a single resource. With the advent of managed care and demands for quicker, more robust treatment responses, even in a tertiary care population, this book can be a very worthwhile addition to a clinician's library.

From the Publisher

"This book deeply taps the rich repository of clinicians and clinical experience which has been developed in the Psychiatry group at the Massachusetts General Hospital over the past several decades. Their approach to patients is the best one in my opinion. They begin with rigorously derived empirical data which guide their decisions. However, when they reach the edge of what the field knows from scientific clinical trials, they utilize the collective experience and wisdom of this seasoned group of excellent clinicians." --James C. Ballenger, MD, Professor and Chairman; Director, Institute of Psychiatry, Medical University of South Carolina

"The book, Challenges in Clinical Practice, is a state-of-the-science text of the biopsychosocial model in action. It should be a 'must' text on the shelf of every mental health researcher and practitioner, and especially in the hands of every resident in psychiatry and graduate student in clinical psychology. It certainly will be used by me in teaching residents in my clinical classes." --Al. S. Fedoravicius, Ph.D., Chief, Psychology Service, VA Medical Center, Albuquerque; Depts of Psychology and Psychiatry, University of New Mexico

"Modern day mental health clinicians now have powerful empirically supported drug and psychosocial treatments in their armamentarium for the majority of mental disorders, and yet most clinicians are all too aware of the large number of treatment resistant patients who fail to benefit sufficiently from these interventions. Now, three of the leading clinicians and clinical scientists in the country from the Massachusetts General Hospital address the issue of treatment resistant patients, bringing to bear the latest information on this difficult issue. Particularly noteworthy is that these distinguished clinicians are accustomed to integrating drug and psychosocial treatments in clinical care in their setting. Therefore, clinicians everywhere confronting treatment-resistant patients can benefit from the newest integrative strategies for helping these individuals. This book should be on every clinician's shelf." --David H. Barlow, Ph.D., Professor and Director of Clinical Programs, Boston University

Doody's Review Service

Reviewer: Jeffrey S. Ross, MD (Rush University Medical Center)Description: This is the first edition of a general psychiatric text reviewing the strategies for the treatment of major mental disorders that have failed first line therapies.Purpose: The purpose is to provide the mental health clinician with a comprehensive literature review of treatment options for the treatment-resistant patient. Unlike other books that focus on a specific disorder and its treatment, this book provides a unique overview of strategies for second-line treatment of the many common psychiatric disorders seen in clinical practice, and it addresses both medication and cognitive therapy options.Audience: Although not specifically stated, the intended audience includes all mental health practitioners, especially psychiatrists, who are increasingly expected to manage with proficiency the first-line treatment failure. The editors have compiled an impressive array of clinical psychopharmacology researchers, mostly Harvard-based, to author the individual chapters, and they do a superb job.Features: The book consists of mostly text, but also includes occasional clinically useful tables, graphs, and treatment algorithms. The references appear mostly current, at least through early 1995. The table of contents and index are well organized and complete, and the appearance of the book is simple but effective.Assessment: This is a very well-organized, well-written, and thoroughly researched general psychiatric textbook covering sophisticated management approaches for the first-line treatment failure. Although much of the information is highly duplicated in the many disorder-specific textbooks available, this book appears unique in compiling this clinically invaluable information into a single resource. With the advent of managed care and demands for quicker, more robust treatment responses, even in a tertiary care population, this book can be a very worthwhile addition to a clinician's library.

Jeffrey S. Ross

This is the first edition of a general psychiatric text reviewing the strategies for the treatment of major mental disorders that have failed first line therapies. The purpose is to provide the mental health clinician with a comprehensive literature review of treatment options for the treatment-resistant patient. Unlike other books that focus on a specific disorder and its treatment, this book provides a unique overview of strategies for second-line treatment of the many common psychiatric disorders seen in clinical practice, and it addresses both medication and cognitive therapy options. Although not specifically stated, the intended audience includes all mental health practitioners, especially psychiatrists, who are increasingly expected to manage with proficiency the first-line treatment failure. The editors have compiled an impressive array of clinical psychopharmacology researchers, mostly Harvard-based, to author the individual chapters, and they do a superb job. The book consists of mostly text, but also includes occasional clinically useful tables, graphs, and treatment algorithms. The references appear mostly current, at least through early 1995. The table of contents and index are well organized and complete, and the appearance of the book is simple but effective. This is a very well-organized, well-written, and thoroughly researched general psychiatric textbook covering sophisticated management approaches for the first-line treatment failure. Although much of the information is highly duplicated in the many disorder-specific textbooks available, this book appears unique in compiling this clinically invaluable information into a single resource. With the advent of managedcare and demands for quicker, more robust treatment responses, even in a tertiary care population, this book can be a very worthwhile addition to a clinician's library.

Booknews

Contributors from pharmacology and psychiatry consider what measures a clinician might take when a patient has failed to respond to initial interventions. They focus on empirically supported treatments, but also range into larger management issues and strategies. Most chapters discuss a particular disorder, including depression, panic, eating disorders, schizophrenia, and personality disorder. Two address the side effects of antidepressants and neuroleptics. Annotation c. Book News, Inc., Portland, OR (booknews.com)
4 Stars! from Doody

Related Subjects

Meet the Author

Mark H. Pollack, M.D., is Director of the Anxiety Disorders Program at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.

Michael W. Otto, Ph.D. is currently the Director of the Cognitive-Behavior Therapy Program at the Massachusetts General Hospital and Assistant Professor of Psychology at Harvard Medical School.

Jerrold F. Rosenbaum, M.D., is Director of the Outpatient Psychiatry Division and Chief of the Clinical Psychopharmacology Unit at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.

Your Rating:

Your Recommendations:

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked,
or didn't, with others. By submitting an online review, you are representing to
Barnes & Noble.com that all information contained in your review is original
and accurate in all respects, and that the submission of such content by you
and the posting of such content by Barnes & Noble.com does not and will not
violate the rights of any third party. Please follow the rules below to help
ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer.
However, we cannot allow persons under the age of 13 to have accounts at BN.com or
to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the
information on the product page, please send us an email.

Reminder:

- By submitting a review, you grant to Barnes & Noble.com and its
sublicensees the royalty-free, perpetual, irrevocable right and license to use the
review in accordance with the Barnes & Noble.com Terms of Use.

- Barnes & Noble.com reserves the right not to post any review -- particularly
those that do not follow the terms and conditions of these Rules. Barnes & Noble.com
also reserves the right to remove any review at any time without notice.